- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04991558
Feasibility and Effectiveness of a Coordinated Healthcare Circuit Dedicated to Patients With Handicap (INFRA)
Prospective, Single-center Observational Study to Assess the Feasibility and Evaluate the Effectiveness of a Coordinated Healthcare Circuit Dedicated to Patients With Mental and Physical Disabilities Undergoing Planned Surgery
France currently has more than 10 million disabled people, including 3 millions who could be better treated. In fact, people with disabilities face many obstacles in accessing care and receiving appropriate support (physical access to certain locations, communication...). Difficulties are also encountered by the healthcare staff, leading to often heterogeneous practices in health establishments.
The INFRA health circuit has been set up at the "Groupe Hospitalier Mutualiste de Grenoble" since June 2018 according to the guidelines published by the French High Authority for Health (HAS) on improving professional practices "Reception, support and organization of care in health establishments for people in situation of handicap "of July 2017. The INFRA nurse collects and anticipates the necessary adaptations for the patient's stay, in conjunction with their caregivers (whether family or institutional). They are an interface with other healthcare professionals to adapt care procedures and protocols (body care, feeding methods, pain management, drug management) to the patient's disability. Before hospitalization and until the patient is discharged, the INFRA nurse transmits to the personnel involved all the information necessary for the proper continuation of care. In addition to legal and regulatory obligations, the INFRA nurse ensures the effective accessibility of the establishment's facilities and premises, and helps maintaining patient autonomy.
The INFRA study is an observational study aimed at assessing the feasibility of the INFRA health circuit and evaluating the benefit for the patients and the healthcare staff.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Grenoble, France, 38028
- Groupe hospitalier mutualiste de Grenoble
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 13 years old or more
- Physical or mental disability, according to french law n°2005-102 of February 11th, 2005
- Requiring an adaptation of the healthcare circuit
- Indication of a planned surgical procedure
Exclusion Criteria:
- Outpatient
- Emergency surgery
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of patients who followed the entirety of INFRA circuit
Time Frame: At discharge, assessed up to 4 weeks
|
At discharge, assessed up to 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Type of pain evaluation scale selected by the INFRA nurse
Time Frame: enrollment
|
enrollment
|
|
|
Number of healthcare adaptations implemented during hospitalization
Time Frame: At discharge, assessed up to 4 weeks
|
At discharge, assessed up to 4 weeks
|
|
|
Satisfaction of patients and caregivers
Time Frame: At discharge, assessed up to 4 weeks
|
Satisfaction survey answered by patients and caregivers
|
At discharge, assessed up to 4 weeks
|
|
Satisfaction of healthcare staff
Time Frame: At discharge, assessed up to 4 weeks
|
Satisfaction survey answered by healthcare staff
|
At discharge, assessed up to 4 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2019/09-ERA-GHMG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disabilities Mental
-
Giovanni CioniAzienda USL Toscana Nord Ovest; Scuola Superiore Sant'Anna di PisaRecruitingCongenital and Acquired Developmental DisabilitiesItaly
-
University Hospital, BrestRecruitingStakeholder Perspectives on the Need for a Digital Solution in Pediatric Rehabilitation (ProChRehab)Children | Disability Physical | Disabilities Multiple | Disability, DevelopmentalFrance
-
Georgia Southern UniversityCompletedDevelopmental Disabilities | Health Education | Community Health Services | Health Services for Persons With DisabilitiesUnited States
-
Oregon Health and Science UniversityNot yet recruitingRehabilitation | Developmental Disability | Assistive Technology | Early Intervention | Cerebral Palsy Children | Motor DisabilitiesUnited States
-
Riphah International UniversityNot yet recruitingDevelopmental Delay (Disorder)Pakistan
-
Western Sussex Hospitals NHS TrustBrighton & Sussex Medical SchoolCompletedDevelopmental DisabilitiesUnited Kingdom
-
Mahidol UniversityCompleted
-
Avera McKennan Hospital & University Health CenterCompleted
-
Ono Academic CollegeCompletedMental Retardation and Developmental Disabilities With Organic Condition
-
Temple UniversityNational Institute on Disability, Independent Living, and Rehabilitation...Enrolling by invitationIntellectual and Developmental DisabilityUnited States